+34 93 169 65 51 info@eignapharma.com

The EMA has updated their Q&A document on the new EV System; new questions have been added (collected from the Service Desk and from EMA webinars held), and several responses have been updated. The EMA recommends consulting this document before contacting the Service Desk. You can check the document here.